These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat. Dankó I; Jia Z; Zhang G Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703 [TBL] [Abstract][Full Text] [Related]
4. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats. Jia Z; Dankó I Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256 [TBL] [Abstract][Full Text] [Related]
5. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome. Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428 [TBL] [Abstract][Full Text] [Related]
6. Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia. Montenegro-Miranda PS; Sneitz N; de Waart DR; Ten Bloemendaal L; Duijst S; de Knegt RJ; Beuers U; Finel M; Bosma PJ Biochim Biophys Acta; 2012 Aug; 1822(8):1223-9. PubMed ID: 22546842 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. Li Q; Murphree SS; Willer SS; Bolli R; French BA Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311 [TBL] [Abstract][Full Text] [Related]
8. AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar. Greig JA; Nordin JML; Draper C; Bell P; Wilson JM Hum Gene Ther; 2018 Jul; 29(7):763-770. PubMed ID: 29448836 [TBL] [Abstract][Full Text] [Related]
9. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Kren BT; Parashar B; Bandyopadhyay P; Chowdhury NR; Chowdhury JR; Steer CJ Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10349-54. PubMed ID: 10468611 [TBL] [Abstract][Full Text] [Related]
10. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Askari FK; Hitomi Y; Mao M; Wilson JM Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798 [TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats. Seppen J; Bakker C; de Jong B; Kunne C; van den Oever K; Vandenberghe K; de Waart R; Twisk J; Bosma P Mol Ther; 2006 Jun; 13(6):1085-92. PubMed ID: 16581301 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector. van der Wegen P; Louwen R; Imam AM; Buijs-Offerman RM; Sinaasappel M; Grosveld F; Scholte BJ Mol Ther; 2006 Feb; 13(2):374-81. PubMed ID: 16337205 [TBL] [Abstract][Full Text] [Related]
13. Gunn Rats as a Surrogate Model for Evaluation of Hepatocyte Transplantation-Based Therapies of Crigler-Najjar Syndrome Type 1. Polgar Z; Li Y; Li Wang X; Guha C; Roy-Chowdhury N; Roy-Chowdhury J Methods Mol Biol; 2017; 1506():131-147. PubMed ID: 27830550 [TBL] [Abstract][Full Text] [Related]
14. Human neonatal hepatocyte transplantation induces long-term rescue of unconjugated hyperbilirubinemia in the Gunn rat. Tolosa L; López S; Pareja E; Donato MT; Myara A; Nguyen TH; Castell JV; Gómez-Lechón MJ Liver Transpl; 2015 Jun; 21(6):801-11. PubMed ID: 25821167 [TBL] [Abstract][Full Text] [Related]
15. Improved efficacy and reduced toxicity by ultrasound-guided intrahepatic injections of helper-dependent adenoviral vector in Gunn rats. Pastore N; Nusco E; Piccolo P; Castaldo S; Vaníkova J; Vetrini F; Palmer DJ; Vitek L; Ng P; Brunetti-Pierri N Hum Gene Ther Methods; 2013 Oct; 24(5):321-7. PubMed ID: 23947957 [TBL] [Abstract][Full Text] [Related]
16. Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle. Pastore N; Nusco E; Vaníkova J; Sepe RM; Vetrini F; McDonagh A; Auricchio A; Vitek L; Brunetti-Pierri N Hum Gene Ther; 2012 Oct; 23(10):1082-9. PubMed ID: 22765254 [TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II]. Drenth JP; Peters WH; Jansen JB Ned Tijdschr Geneeskd; 2002 Aug; 146(32):1488-90. PubMed ID: 12198827 [TBL] [Abstract][Full Text] [Related]
18. Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked plasmid DNA into muscle. Jia Z; Dankó I Mol Ther; 2005 Nov; 12(5):860-6. PubMed ID: 16019265 [TBL] [Abstract][Full Text] [Related]
19. Correction of congenital indirect hyperbilirubinemia by small intestinal transplantation. Medley MM; Hooker RL; Rabinowitz S; Holton R; Jaffe BM Am J Surg; 1995 Jan; 169(1):20-7. PubMed ID: 7817994 [TBL] [Abstract][Full Text] [Related]
20. Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Servedio V; d'Apolito M; Maiorano N; Minuti B; Torricelli F; Ronchi F; Zancan L; Perrotta S; Vajro P; Boschetto L; Iolascon A Hum Mutat; 2005 Mar; 25(3):325. PubMed ID: 15712364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]